DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Lefebvre E, Moyle G, Reshef R , et al.
Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis.
PLoS One 2016;
11 (6) e0158156
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.